Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Sales revenue	$ 0	$ 0
Cost of goods sold	0	0
Gross profit	0	0
General and administrative expenses	459,517	493,405
LOSS FROM OPERATIONS	(459,517)	(493,405)
OTHER EXPENSE
Interest expense	(38,572)	(65,254)
Total other expense	(38,572)	(65,254)
LOSS BEFORE INCOME TAXES	(498,089)	(558,659)
Income tax expense	0	0
LOSS FROM CONTINUING OPERATIONS	(498,089)	(558,659)
Loss from discontinued operations	0	73,758
NET LOSS	(498,089)	(632,417)
Net loss attributable to common stockholders of GB Sciences, Inc. - basic and diluted
Continuing operations, basic	498,089	558,659
Discontinued operations, basic	0	73,758
Net loss	$ (498,089)	$ (632,417)
Net loss per common share – basic and diluted
Continuing operations (in dollars per share)	$ (0.00)	$ (0.00)
Discontinued operations (in dollars per share)	0	(0.00)
Net loss (in dollars per share)	$ (0.00)	$ (0.00)
Weighted average common shares outstanding - basic and diluted (in shares)	325,743,436	315,675,539